Home LiteratureArticle Details
PMID: 12604539 Published · ppublish English Journal Article

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Antimicrobial agents and chemotherapy ·Vol. 47 ·No. 3 ·2003-03-00 ·Pages 1037-46

Gross CH, Parsons JD, Grossman TH, Charifson PS, Bellon S, Jernee J, Dwyer M, Chambers SP, Markland W, Botfield M, Raybuck SA

Abstract

DNA gyrase is a bacterial type II topoisomerase which couples the free energy of ATP hydrolysis to the introduction of negative supercoils into DNA. Amino acids in proximity to bound nonhydrolyzable ATP analog (AMP. PNP) or novobiocin in the gyrase B (GyrB) subunit crystal structures were examined for their roles in enzyme function and novobiocin resistance by site-directed mutagenesis. Purified Escherichia coli GyrB mutant proteins were complexed with the gyrase A subunit to form the functional A(2)B(2) gyrase enzyme. Mutant proteins with alanine substitutions at residues E42, N46, E50, D73, R76, G77, and I78 had reduced or no detectable ATPase activity, indicating a role for these residues in ATP hydrolysis. Interestingly, GyrB proteins with P79A and K103A substitutions retained significant levels of ATPase activity yet demonstrated no DNA supercoiling activity, even with 40-fold more enzyme than the wild-type enzyme, suggesting that these amino acid side chains have a role in the coupling of the two activities. All enzymes relaxed supercoiled DNA to the same extent as the wild-type enzyme did, implying that only ATP-dependent reactions were affected. Mutant genes were examined in vivo for their abilities to complement a temperature-sensitive E. coli gyrB mutant, and the activities correlated well with the in vitro activities. We show that the known R136 novobiocin resistance mutations bestow a significant loss of inhibitor potency in the ATPase assay. Four new residues (D73, G77, I78, and T165) that, when changed to the appropriate amino acid, result in both significant levels of novobiocin resistance and maintain in vivo function were identified in E. coli.

MeSH Terms
Adenosine Triphosphatases/metabolism Adenosine Triphosphate/metabolism Alleles Amino Acid Substitution/genetics Anti-Bacterial Agents/pharmacology Binding Sites Cloning, Molecular DNA Gyrase/genetics,metabolism DNA, Superhelical/genetics,metabolism Drug Resistance, Bacterial Escherichia coli/drug effects,enzymology,genetics Hydrolysis Kinetics Models, Molecular Mutagenesis, Site-Directed Novobiocin/pharmacology Recombinant Proteins/biosynthesis,isolation & purification Structure-Activity Relationship Temperature
Chemicals
Anti-Bacterial Agents DNA, Superhelical Recombinant Proteins Novobiocin Adenosine Triphosphate Adenosine Triphosphatases DNA Gyrase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Gross Christian H
Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts 02139, USA. [email protected]
Parsons Jonathan D
Grossman Trudy H
Charifson Paul S
Bellon Steven
Jernee James
Dwyer Maureen
Chambers Stephen P
Markland William
Botfield Martyn
Raybuck Scott A
References (48)
48 references, click to expand
  1. An unusual mechanism for resistance to the antibiotic coumermycin A1.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8860-4 PMID: 1656457
  2. Timely release of both replication forks from oriC requires modulation of origin topology.
    J Biol Chem. 2001 Oct 19;276(42):39186-91 PMID: 11504719
  3. The interaction of the F plasmid killer protein, CcdB, with DNA gyrase: induction of DNA cleavage and blocking of transcription.
    J Mol Biol. 1997 Nov 7;273(4):826-39 PMID: 9367775
  4. Mutation in the DNA gyrase A Gene of Escherichia coli that expands the quinolone resistance-determining region.
    Antimicrob Agents Chemother. 2001 Aug;45(8):2378-80 PMID: 11451702
  5. Isolation and characterisation of a strain carrying a conditional lethal mutation in the cou gene of Escherichia coli K12.
    Mol Gen Genet. 1979;177(1):103-12 PMID: 94144
  6. DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism.
    Cell. 1994 May 20;77(4):609-16 PMID: 8187179
  7. Hydrolysis of ATP at only one GyrB subunit is sufficient to promote supercoiling by DNA gyrase.
    J Biol Chem. 1998 Oct 9;273(41):26305-9 PMID: 9756859
  8. Inactivation of antibiotics and the dissemination of resistance genes.
    Science. 1994 Apr 15;264(5157):375-82 PMID: 8153624
  9. Regulation of the genes for E. coli DNA gyrase: homeostatic control of DNA supercoiling.
    Cell. 1983 Aug;34(1):105-13 PMID: 6309403
  10. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
    Biochemistry. 1996 Apr 16;35(15):5083-92 PMID: 8664301
  11. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
    Biochemistry. 1997 Aug 12;36(32):9663-73 PMID: 9245398
  12. gyrB mutations in coumermycin A1-resistant Borrelia burgdorferi.
    J Bacteriol. 1994 May;176(10):3072-5 PMID: 8188609
  13. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Protein Sci. 1998 Nov;7(11):2249-55 PMID: 9827991
  14. Conversion of DNA gyrase into a conventional type II topoisomerase.
    Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14416-21 PMID: 8962066
  15. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines revealed by X-ray crystallography.
    EMBO J. 1996 Mar 15;15(6):1412-20 PMID: 8635474
  16. Probing the binding of coumarins and cyclothialidines to DNA gyrase.
    Biochemistry. 1999 Feb 16;38(7):1967-76 PMID: 10026280
  17. Mutations in the B subunit of Escherichia coli DNA gyrase that affect ATP-dependent reactions.
    J Biol Chem. 1996 Apr 19;271(16):9723-9 PMID: 8621650
  18. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance.
    Clin Infect Dis. 1998 Aug;27 Suppl 1:S54-63 PMID: 9710672
  19. DNA gyrase as a drug target.
    Trends Microbiol. 1997 Mar;5(3):102-9 PMID: 9080608
  20. Exploiting nucleotide thiophosphates to probe mechanistic aspects of Escherichia coli DNA gyrase.
    Biochemistry. 1997 May 20;36(20):6059-68 PMID: 9166776
  21. DNA gyrase action involves the introduction of transient double-strand breaks into DNA.
    Proc Natl Acad Sci U S A. 1980 Apr;77(4):1847-51 PMID: 6246508
  22. Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance.
    J Bacteriol. 1995 Jul;177(14):4166-70 PMID: 7608096
  23. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
    Proc Natl Acad Sci U S A. 1976 Dec;73(12):4474-8 PMID: 794878
  24. Coumermycin A1: A preferential inhibitor of replicative DNA synthesis in Escherichia coli. I. In vivo characterization.
    Biochemistry. 1976 AUG 24;15(17):3769-77 PMID: 782522
  25. The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs.
    Biochemistry. 1993 Mar 16;32(10):2717-24 PMID: 8383523
  26. Locking the DNA gate of DNA gyrase: investigating the effects on DNA cleavage and ATP hydrolysis.
    Biochemistry. 1999 Oct 26;38(43):14157-64 PMID: 10571989
  27. The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases.
    Cell. 1992 Nov 27;71(5):833-40 PMID: 1330327
  28. The DNA dependence of the ATPase activity of DNA gyrase.
    J Biol Chem. 1984 Dec 10;259(23):14472-80 PMID: 6094559
  29. Mutations in DNA gyrase result in novobiocin resistance in halophilic archaebacteria.
    J Bacteriol. 1991 Jan;173(2):642-8 PMID: 1846146
  30. Probing the role of the ATP-operated clamp in the strand-passage reaction of DNA gyrase.
    Nucleic Acids Res. 1996 Dec 15;24(24):4868-73 PMID: 9016655
  31. Identifying the catalytic residue of the ATPase reaction of DNA gyrase.
    Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11232-6 PMID: 8248233
  32. Isolation and characterization of Bacillus subtilis genes involved in siderophore biosynthesis: relationship between B. subtilis sfpo and Escherichia coli entD genes.
    J Bacteriol. 1993 Oct;175(19):6203-11 PMID: 8407792
  33. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4838-42 PMID: 368801
  34. DNA sequence of the E. coli gyrB gene: application of a new sequencing strategy.
    Nucleic Acids Res. 1987 Jan 26;15(2):771-84 PMID: 3029692
  35. Crystal structure of an N-terminal fragment of the DNA gyrase B protein.
    Nature. 1991 Jun 20;351(6328):624-9 PMID: 1646964
  36. Probing the two-gate mechanism of DNA gyrase using cysteine cross-linking.
    Biochemistry. 1999 Oct 12;38(41):13502-11 PMID: 10521257
  37. Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
    Biochemistry. 1998 Jul 7;37(27):9658-67 PMID: 9657678
  38. Mechanisms of fluoroquinolone resistance.
    Drug Resist Updat. 1999 Feb;2(1):38-55 PMID: 11504468
  39. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Antimicrob Agents Chemother. 2001 Aug;45(8):2263-8 PMID: 11451683
  40. Spontaneous cAMP-dependent derepression of gene expression in stationary phase plays a role in recombinant expression instability.
    Gene. 1998 Mar 16;209(1-2):95-103 PMID: 9524234
  41. Dimerization of Escherichia coli DNA-gyrase B provides a structural mechanism for activating the ATPase catalytic center.
    J Biol Chem. 2000 Mar 31;275(13):9468-75 PMID: 10734094
  42. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
    Mol Microbiol. 1992 Jun;6(12):1617-24 PMID: 1323022
  43. Locking the ATP-operated clamp of DNA gyrase: probing the mechanism of strand passage.
    J Mol Biol. 2001 Mar 9;306(5):969-84 PMID: 11237612
  44. Prevention of drug access to bacterial targets: permeability barriers and active efflux.
    Science. 1994 Apr 15;264(5157):382-8 PMID: 8153625
  45. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Antimicrob Agents Chemother. 1996 Apr;40(4):1060-2 PMID: 8849232
  46. A model for the mechanism of strand passage by DNA gyrase.
    Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8414-9 PMID: 10411889
  47. Resistance to antibiotics mediated by target alterations.
    Science. 1994 Apr 15;264(5157):388-93 PMID: 8153626
  48. Evidence for a conformational change in the DNA gyrase-DNA complex from hydroxyl radical footprinting.
    Nucleic Acids Res. 1994 May 11;22(9):1567-75 PMID: 8202356
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
2003-03-00
Pages
1037-46
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC149296
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]